ATE445408T1 - Verwendung von prolactin in der prophylaktischen krebstherapie - Google Patents
Verwendung von prolactin in der prophylaktischen krebstherapieInfo
- Publication number
- ATE445408T1 ATE445408T1 AT06826240T AT06826240T ATE445408T1 AT E445408 T1 ATE445408 T1 AT E445408T1 AT 06826240 T AT06826240 T AT 06826240T AT 06826240 T AT06826240 T AT 06826240T AT E445408 T1 ATE445408 T1 AT E445408T1
- Authority
- AT
- Austria
- Prior art keywords
- prolactin
- cancer therapy
- prophylactic cancer
- prophylactic
- compositions
- Prior art date
Links
- 102000003946 Prolactin Human genes 0.000 title abstract 2
- 108010057464 Prolactin Proteins 0.000 title abstract 2
- 229940097325 prolactin Drugs 0.000 title abstract 2
- 238000011275 oncology therapy Methods 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2257—Prolactin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72829705P | 2005-10-20 | 2005-10-20 | |
| US76389206P | 2006-02-01 | 2006-02-01 | |
| PCT/US2006/040806 WO2007047803A2 (en) | 2005-10-20 | 2006-10-19 | Use of prolactin in the prophylactic treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE445408T1 true ATE445408T1 (de) | 2009-10-15 |
Family
ID=37963261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06826240T ATE445408T1 (de) | 2005-10-20 | 2006-10-19 | Verwendung von prolactin in der prophylaktischen krebstherapie |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100041598A1 (de) |
| EP (1) | EP1959985B1 (de) |
| AT (1) | ATE445408T1 (de) |
| CA (1) | CA2626785A1 (de) |
| DE (1) | DE602006009840D1 (de) |
| WO (1) | WO2007047803A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0108043A (pt) * | 2000-02-01 | 2003-04-01 | Stevia Aps | Substância para uso em complementação de dieta ou para preparação de um medicamento para o tratamento de diabetes melito não-dependente de insulina, hipertensão e/ou sìndrome metabólica |
| EP2531211A4 (de) | 2010-02-03 | 2013-10-23 | Orbis Health Solutions Llc | Verfahren zur sensibilisierung von zellen für eine krebstherapie |
| EP2526961A1 (de) * | 2011-05-26 | 2012-11-28 | Mario Sargentini | Behandlung oder Linderung einige neuroendokrine Erkrankungen bei männlichen mit Hilfe von Prolaktin |
| EP3996737A4 (de) * | 2019-07-09 | 2023-06-14 | Lateral Ip Pty Ltd | Peptide und ihre verwendungen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080728A (en) * | 1996-07-16 | 2000-06-27 | Mixson; A. James | Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy |
| AU4308699A (en) * | 1998-05-12 | 1999-11-29 | Greenville Hospital System | Use of anti-prolactin agents to treat proliferative conditions |
| AU2003264177A1 (en) * | 2002-09-25 | 2004-04-19 | Garvan Institute Of Medical Research | Method for inducing mammary epithelial cell differentiation |
-
2006
- 2006-10-19 US US12/083,865 patent/US20100041598A1/en not_active Abandoned
- 2006-10-19 DE DE602006009840T patent/DE602006009840D1/de active Active
- 2006-10-19 EP EP06826240A patent/EP1959985B1/de not_active Not-in-force
- 2006-10-19 AT AT06826240T patent/ATE445408T1/de not_active IP Right Cessation
- 2006-10-19 WO PCT/US2006/040806 patent/WO2007047803A2/en not_active Ceased
- 2006-10-19 CA CA002626785A patent/CA2626785A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20100041598A1 (en) | 2010-02-18 |
| EP1959985B1 (de) | 2009-10-14 |
| EP1959985A2 (de) | 2008-08-27 |
| CA2626785A1 (en) | 2007-04-26 |
| DE602006009840D1 (de) | 2009-11-26 |
| WO2007047803A2 (en) | 2007-04-26 |
| WO2007047803A3 (en) | 2007-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100051I1 (hu) | Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére | |
| IL258880A (en) | Diarylhydantoin compounds | |
| MX2009006466A (es) | Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina. | |
| TR200906131T1 (tr) | Aktivin -actrIIa antagonistleri ve göğüs kanserinin tedavi e | |
| MX2007011545A (es) | Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr. | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| MX2007002398A (es) | Nuevas composiciones farmaceuticas para el tratamiento de cancer. | |
| EA201000016A1 (ru) | Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями | |
| MX361467B (es) | Compuestos de isoindolina para uso en el tratamiento de cancer. | |
| DE602006014843D1 (de) | Verwendung von hif 1alfa modulatoren zur behandlung von krebs | |
| EA201290356A1 (ru) | Композиции для лечения тошноты и рвоты центрального происхождения | |
| MXPA05013822A (es) | Pirrolodihidroisoquinolinas utiles en el tratamiento del cancer. | |
| UA89226C2 (en) | Imidazole compounds | |
| MA32544B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
| MY149606A (en) | Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment | |
| MX360301B (es) | Moleculas pequeñas que contienen boro como agentes antiinflamatorios. | |
| NO20055741D0 (no) | Nye kjemiske forbindelser | |
| EA201170447A1 (ru) | Производные изохинолинона в качестве антагонистов nk3 | |
| EA200701995A1 (ru) | Способы уменьшения кальцификации | |
| MX2025004473A (es) | Novedosos anticuerpos anti-napi2b y conjugados-anticuerpo-droga basados en ellos, metodos terapeuticos y usos de los mismos | |
| DE602004019541D1 (de) | Cycloalkyläbü kondensierte indole | |
| ATE542796T1 (de) | N-sulfonylcarboximidamidverbindungen als apoptosepromotoren | |
| DE602006009840D1 (de) | Verwendung von prolactin in der prophylaktischen krebstherapie | |
| DE602005015329D1 (de) | Rutheniumkomplexe zur krebsbehandlung | |
| EA200702136A1 (ru) | Композиции станнсопорфина и их применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |